BIO.AX(BIO.AX)
BIO.AX
No analyst ratings available
No analyst price targets available for BIO.AX
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $33M | $45M |
| Low | $33M | $45M |
| High | $33M | $45M |
| EBITDA Avg | $-17M | $-23M |
| Low | $-17M | $-23M |
| High | $-17M | $-23M |
| EBIT Avg | $-17M | $-24M |
| Low | $-17M | $-24M |
| High | $-17M | $-24M |
| Net Income Avg | $5M | $7M |
| Low | $5M | $7M |
| High | $5M | $7M |
| EPS Avg | $0.02 | $0.03 |
| Low | $0.02 | $0.03 |
| High | $0.02 | $0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |